TABLE 2.
PCR amplification products and CagA proteins from Japanese patients with gastric carcinoma
| Patienta | Age (yr) | Sexb | Cancer stage | Atrophy score (median) | PG I/II ratio | AntiCagA scorec | Strain type | PCR product (bp) | CagA protein (K)d |
|---|---|---|---|---|---|---|---|---|---|
| JK 19 | 46 | M | Early | 2.5 | 1.4 | 52.5 | C | 810 | 141 |
| JK 68 | 76 | F | Early | 3 | 1.0 | 23.9 | C | 810 | 141 |
| JK 74 | 73 | F | Advanced | 3 | 2.3 | 100 | C | 810 | 141 |
| JK 215 | 62 | M | Early | 3 | 1.8 | 46.5 | C | 810 | 141 |
| JK 269 | 60 | M | Early | 3 | 1.0 | 23.1 | C | 810 | 142 |
| JK 275 | 55 | F | Advanced | 3 | 1.8 | 100 | C | 810 | 142 |
| JK 260 | 75 | M | Early | 1 | 3.0 | 15.5 | A | 648 | 129 |
| JK 273 | 59 | M | Early | 0.5 | 5.9 | 7.2 | A | 648 | 129 |
| JK 256 | 68 | F | Early | 1 | 2.7 | 7.4 | A | 648 | 135 |
| JK 69 | 76 | F | Early | 3 | 1.3 | 19.7 | A | 648 | 135 |
| JK 83 | 71 | M | Early | 2 | 1.6 | 8.1 | A | 651 | 135 |
| JK 34 | 28 | M | Early | 1 | 4.1 | 22.6 | A | 648 | 135 |
| JK 42 | 76 | M | Early | 2 | 1.5 | 36.7 | A | 642 | 135 |
| JK 217 | 64 | F | Early | 2 | 2.1 | 9.5 | A | 642 | 137 |
| JK 96 | 59 | M | Early | 1 | 5.9 | 8.2 | A | 648 | 136 |
| JK 55 | 68 | M | Early | 1 | 2.7 | 96.1 | A | 651 | 129 |
a
Data for strains from the remaining patients is not shown because sequence analysis or Western blotting was not performed; however, atrophy scores, PG I/II ratios, anti-CagA scores, and PCR product sizes were available for analysis (see Results).
b
M, male; F, female.
c
Cutoff, 5.0.
d
Determined by immunoblotting.